One possible explanation that researchers have explored concerns the differences in the cells and in the nerves that send pain signals to the brain in women and in men. The results of the study suggest that new therapies for the management of pain addressed to the system of the prolactin would be of great benefit to women who suffer from pain syndromes functional. The researchers remind us that the spikes of pain are intermittent and are associated with triggering events. And that stress causes release of prolactin.
Medicines dopamine receptor agonists and D-2 that limit the release of prolactin, such as cabergoline, are commonly used for other diseases and they are not addictive. These drugs, possibly in combination with other classes of drugs, can help treat pain conditions in women in the most effective way, without the addictive properties of opioids.
"The Republic will fight always in defense of the freedom of information, to its readers and to all those who have at heart the principles of democracy and civil coexistence"Carlo Verdelli SUBSCRIBERS TO REPUBLIC © Reproduction reserved Today on The torments of the Count: “But there rialzeremo as after the bridge Morandi”, Giuseppe Sala: “Milan is the trench that must withstand. By the government making the right choices,” The crisis in the airports: passengers on the decline up to 65% off the government to The trade unions: up to 4 billion for the shock absorbers and smes The freedom hostage